The dilemmas of the European Union's open access to data policy

The dilemmas of the European Union's open access to data policy
复制标题

欧盟开放数据政策的困境

DOI:
10.1016/s0140-6736(17)31458-7
复制
发表时间:
2017
期刊:
The Lancet
影响因子:
--
通讯作者:
E. Zambelli
E. Zambelli
中科院分区:
--
文献类型:
--
作者:
B. Destremau;R. Giacaman;Mona Harb;L. Herrera;Maria M. Mexi;Suzan Mitwalli;E. Murphy;Yoke Rabaia;Lynn Welchman;E. Zambelli

文献摘要

被引文献

相似文献

通信www.我的天使2017年7月8日123研究和政策制定过程,从而解决研究设计和研究人群的需求之间缺乏一致性。这些知识中介机构旨在使决策者能够理解研究,是Belizan和Miller1建议的LMIC多学科研究中心的重要组成部分,LMIC的研究也受益于有关正在进行的研究的改进信息,包括临床试验,LMIC正在做更多的工作来解决透明度差,问责制和道德不端等问题。世卫组织认识到这些问题,随后建立了国际临床试验登记平台(ICTRP),4使中低收入国家的研究人员能够访问本国和全球的试验。ICTRP促使许多中低收入国家建立了临床试验登记处,并通过促进研究人员之间的合作和最大限度地利用稀缺资源和设施来提高研究效率。
Correspondence www. thelancet. com Vol 390 July 8, 2017 123 the research and policy development process, thus addressing the absence of congruence between the research design and the needs of the study population. These knowledge broker units, which aim to make research understandable to policy makers, are valuable components of the multidisciplinary research centres in LMICs that Belizan and Miller1 proposed.Research in LMICs also benefits from improved information about ongoing research, including clinical trials, with more being done in LMICs to address problems such as poor transparency, accountability, and ethical misconduct. WHO acknowledged these problems, and subsequently established the International Clinical Trials Registry Platform (ICTRP), 4 which enables researchers in LMICs to access trials within their own countries and globally. The ICTRP has led to the creation of clinical trial registries in many LMICs and has improved the efficiency of research by facilitating collaboration between researchers and maximising the use of scarce resources and facilities.